Location History:
- Montréal, CA (2010 - 2011)
- St. Laurent, CA (2012)
- Montreal, CA (2010 - 2024)
Company Filing History:
30 out of 198 
4 out of 6 
1 out of 1 Years Active: 2010-2025
Title: The Innovations of Martin Emile Lachaine: A Pioneer in Cardiac Ablation Technologies
Introduction
Martin Emile Lachaine, based in Montreal, CA, is a distinguished inventor holding 33 patents to his name. His work primarily focuses on advancements in cardiac ablation technology, enhancing the precision and effectiveness of radiotherapy treatments.
Latest Patents
Among his latest innovations is a patented method for **Cardiac Ablation using an MR Linac**. This system includes generating a radiotherapy treatment plan that addresses a myocardial scar using contrast-enhanced magnetic resonance (MR) imaging. The method identifies the ablation volume in another MR image without contrast, adjusts the treatment plan accordingly, and ensures precise delivery of radiotherapy by comparing cine images captured during treatment.
Another notable patent is for **Automatic Gating with an MR Linac**, which streamlines the process of image registration during radiation sessions. This innovation incorporates a trained machine learning model to estimate and align imaging slices with a time-varying object, enabling the generation of updated therapy protocols based on real-time data.
Career Highlights
Martin's career includes key roles at reputable companies such as Elekta, Inc. and Resonant Medical, Inc. His contributions in these organizations have played a significant role in pushing the boundaries of medical technology and patient treatment options.
Collaborations
Throughout his career, Martin has collaborated with talented individuals like Tony Falco and Silvain Bériault. These partnerships have fostered a productive research environment, enabling the development of innovative therapies that significantly benefit patient care.
Conclusion
Martin Emile Lachaine exemplifies the spirit of innovation in the medical technology field. His 33 patents reflect a commitment to advancing cardiac care and improving treatment methodologies. As he continues his work, the impact of his inventions will likely lead to even greater advancements in patient health outcomes.